European Medical Journal

Flu Symptoms Return as Winter Viruses Rebound

After COVID-19 NPIs lifted, respiratory infections reverted toward pre pandemic seasonality, with winter peaks for RSV and ...
Business Wire

QIAGEN Receives FDA Emergency Use Authorization for NeuMoDx Multiplex Test Expanding COVID-19 Portfolio

GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the Emergency Use Authorization by the U.S. FDA for the NeuMoDx™ Flu A-B/RSV ...
Business Wire

Hologic’s Multiplex COVID-19/Flu Test Now Commercially Available in North America and Europe

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that its Aptima® SARS-CoV-2/Flu Assay is now available for the simultaneous detection and differentiation of three ...
Seeking Alpha

LumiraDx Receives FDA Emergency Use Authorization and UK CTDA Approval for its Fast Lab Solutions Multiplex COVID and Influenza Molecular Assay

LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete assay receives Emergency Use Authorization from the FDA along with being successfully validated by the UK Health Security Agency (UKHSA) under the ...
East Oregonian

Aptitude Receives FDA Authorization for Metrix® COVID/Flu Multiplex Molecular Test for Point-of-Care and Over-the-Counter Use

The FDA-authorized Metrix COVID/Flu molecular test detects and differentiates COVID, Flu A, and B in 20 minutes. It may be used in home and CLIA-waived settings. SANTA BARBARA, Calif., Feb. 24, 2025 ...